Loading
Latest filing published 21 Dec 2018 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.).
No signal scores available.
Sylvain Chretien discloses dealings in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) to SEDI. In total, 2 filings cover trades dated 19 December 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 21 December 2018: a transaction, in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations